|
|
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R93.2 |
Abnormal findings on diagnostic imaging of liver and biliary tract
|
R932 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 24.71%
|
27.67%
|
17.90%
|
10.92%
|
6.31%
|
3.80%
|
2.66%
|
1.66%
|
1.07%
|
0.81%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R93.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,881
|
2,889
|
|
76705
|
ECHO EXAM OF ABDOMEN |
2,388
|
2,391
|
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
2,153
|
2,153
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,594
|
1,594
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1,466
|
133,466
|
|
76700
|
US EXAM ABDOM COMPLETE |
1,450
|
1,450
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,405
|
1,406
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,307
|
1,311
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
1,028
|
1,028
|
|
85610
|
PROTHROMBIN TIME |
1,024
|
1,025
|
|
82565
|
ASSAY OF CREATININE |
1,011
|
1,013
|
|
G1004
|
CDSM NDSC |
769
|
812
|
|
80076
|
HEPATIC FUNCTION PANEL |
661
|
661
|
|
A9585
|
GADOBUTROL INJECTION |
637
|
47,253
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
594
|
594
|
|
A9537
|
TC99M MEBROFENIN |
492
|
492
|
|
82728
|
ASSAY OF FERRITIN |
491
|
492
|
|
83516
|
IMMUNOASSAY NONANTIBODY |
459
|
600
|
|
83540
|
ASSAY OF IRON |
444
|
444
|
|
A9577
|
INJ MULTIHANCE |
426
|
6,440
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R93.2 related to the following DRG Codes:
444-446
|
